BioCryst Pharmaceuticals, Inc.

590 articles about BioCryst Pharmaceuticals, Inc.

• Biocryst Pharmaceuticals Initiates Phase II Clinical Trial to Evaluate Intravenous Peramivir in Patients Hospitalized With Influenza

  7/24/2007

• Roche and Biocryst Pharmaceuticals Advance BCX-4208/R3421 Into Phase II Psoriasis Trial

  7/16/2007

• Biocryst Pharmaceuticals Receives Special Protocol Assessment for Pivotal Trial of Oral Fodosine(TM) in Patients With Cutaneous T-Cell Lymphoma (CTCL)

  7/9/2007

• Biocryst Pharmaceuticals Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference

  6/18/2007

• Biocryst Pharmaceuticals Reports First Quarter 2007 Financial Results

  5/9/2007

• Biocryst Pharmaceuticals to Release First Quarter 2007 Financial Results on Wednesday, May 9, 2007

  5/2/2007

• Biocryst Pharmaceuticals Expands Management Team

  4/3/2007

• SCOLR Pharma, Inc. Announces Research Collaboration with Biocryst Pharmaceuticals

  3/9/2007

• The Day In Review: Novartis Pharmaceuticals Corporation Gets Approval For Hypertensive Drug Tekturna

  3/6/2007

• Biocryst Pharmaceuticals To Present At The 2007 Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/8/2007

• Biocryst Pharmaceuticals Reports Fourth Quarter And Full Year 2006 Financial Results

  2/7/2007

• EMEA Grants Orphan Drug Designation To Biocryst Pharmaceuticals's Fodosine(TM) For The Treatment of Cutaneous T-Cell Lymphoma (CTCL)

  2/6/2007

• Biocryst Pharmaceuticals To Release Fourth Quarter And Year-End 2006

  2/2/2007

• Biocryst Pharmaceuticals Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir

  1/25/2007

• Biocryst Pharmaceuticals Initiates Pivotal Fodosine(TM) Phase IIb Clinical Trial In Patients With Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma

  1/16/2007

• Jon P. Stonehouse Appointed Chief Executive Officer Of Biocryst Pharmaceuticals

  1/8/2007

• Biocryst Pharmaceuticals Wins $103M Bird Flu Contract

  1/5/2007

• Biocryst Pharmaceuticals To Provide Summary Of Data Presented At The 2006 American Society of Hematology Annual Meeting

  12/7/2006

• Biocryst Pharmaceuticals' Fodosine(TM) Data To Be Presented At The 2006 American Society of Hematology

  12/5/2006

• Biocryst Pharmaceuticals's Fodosine(TM) Granted Orphan Status In Europe

  11/20/2006